Search

Your search keyword '"Yong, Jie Ning"' showing total 171 results

Search Constraints

Start Over You searched for: Author "Yong, Jie Ning" Remove constraint Author: "Yong, Jie Ning"
171 results on '"Yong, Jie Ning"'

Search Results

1. Patterns in Cancer Incidence Among People Younger Than 50 Years in the US, 2010 to 2019

2. Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis

3. Meta‐analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin

4. Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis

5. Rising global burden of cancer attributable to high BMI from 2010 to 2019

6. Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies

8. Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD – An Umbrella Overview of Systematic Review of Meta-Analysis

9. UNOS Down-Staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 Studies

11. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis

12. Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis

17. The incidence of adverse outcome in donors after living-donor liver transplantation: A meta-analysis of 60,829 donors

18. Rising global burden of cancer attributable to high BMI from 2010 to 2019

19. The silent burden of non‐alcoholic fatty liver disease in the elderly: A global burden of disease analysis

20. Longitudinal Outcomes Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease. A Meta Analysis of 129 Studies

21. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis

22. Ethnic disparities in waitlist outcomes of patients with nonalcoholic steatohepatitis listed for liver transplantation in the US.

23. Safety and tolerability of obeticholic acid in chronic liver disease: a pooled analysis of 1878 individuals

24. Original article: The prognostic value of including non‐alcoholic fatty liver disease in the definition of metabolic syndrome

25. Examining the interim proposal for name change to steatotic liver disease in the US population

26. De novo metabolic syndrome after liver transplantation: a meta-analysis on cumulative incidence, risk factors, and outcomes

27. Global Prevalence, Clinical Characteristics, Surveillance, Treatment Allocation, and Outcomes Of Alcohol-Associated Hepatocellular Carcinoma: Systematic Review and Meta-Analysis

28. A Meta-analysis on Associated Risk of Mortality in Nonalcoholic Fatty Liver Disease

29. A qualitative systematic review of anonymous/unspecified living kidney and liver donors’ perspectives

30. A network meta-analysis of 12,116 individuals from randomized controlled trials in the treatment of depression after acute coronary syndrome

31. Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD – An Umbrella Overview of Systematic Review of Meta-Analysis

32. Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysis

33. Statins decrease overall mortality and cancer related mortality but are underutilized in NAFLD: a longitudinal analysis of 12,538 individuals

34. Complete alcohol abstinence increases the risk of NAFLD but not severity. A population analysis with transient elastography

35. Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality

36. Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis

37. The prognostic value of including non‐alcoholic fatty liver disease in the definition of metabolic syndrome.

38. Living in the non‐alcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectives

39. Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals

40. 91: COULD NON-ALCOHOLIC STEATOHEPATITIS SPONTANEOUSLY REGRESS? EVIDENCE FROM 2,649 INDIVIDUALS ON PLACEBO IN RANDOMIZED CONTROLLED TRIALS

41. Su1401: NON-ALCOHOLIC FATTY LIVER DISEASE ASSOCIATION WITH STRUCTURAL HEART, SYSTOLIC AND DIASTOLIC DYSFUNCTION. A META-ANALYSIS

42. 868: PREVENTING HEPATCELLULAR CARCINOMA WITH TENOFOVIR VS ENTECAVIR: AN INDIVIDUAL PATIENT DATA META-ANALYSIS OF PROPENSITY SCORE MATCHED STUDIES

43. 437: UNOS-DOWNSTAGING CRITERIA FOR LIVER TRANSPLANTATION OF HEPATOCELLULAR CARCINOMA: SYSTEMATIC REVIEW AND META-ANALYSIS OF 26 STUDIES

44. 92: FOREGUT BYPASS VERSUS RESTRICTIVE BARIATRIC PROCEDURES FOR NONALCOHOLIC FATTY LIVER DISEASE. A META-ANALYSIS OF 1,823 INDIVIDUALS

45. 207: ANALYSIS OF MECHANISTIC PATHWAYS IN THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS: A BAYESIAN NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

46. Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease: A One-Stage Meta-Analysis

47. Meta‐analysis: analysis of mechanistic pathways in the treatment of non‐alcoholic steatohepatitis. Evidence from a Bayesian network meta‐analysis

48. A NETWORK META-ANALYSIS OF 12,116 INDIVIDUALS FROM RANDOMIZED CONTROLLED TRIALS IN THE TREATMENT OF DEPRESSION AFTER ACUTE CORONARY SYNDROME

49. UNOS Down-Staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 Studies

50. Liver resection versus liver transplantation for hepatocellular carcinoma within Milan criteria: a meta-analysis of 18,421 patients

Catalog

Books, media, physical & digital resources